U.S. Capital Markets Stock News

NasdaqCM:FTCI
NasdaqCM:FTCIElectrical

Can FTC Solar’s (FTCI) Rapid Sales Growth Outweigh Persistent Losses in Its Investment Story?

FTC Solar, Inc. recently announced its third quarter 2025 results, reporting revenue of US$26.03 million, up from US$10.14 million a year earlier, while net loss widened to US$23.94 million from US$15.36 million over the same period. Alongside the earnings announcement, the company set its fourth quarter 2025 revenue guidance between US$30.0 million and US$35.0 million, highlighting continued sales momentum despite persistent losses. We’ll explore how this combination of rapid revenue growth...
NasdaqCM:ENGN
NasdaqCM:ENGNBiotechs

enGene Holdings (ENGN) Valuation in Focus Following Promising Phase 2 Bladder Cancer Trial Results

enGene Holdings (ENGN) is drawing attention after announcing positive preliminary results from the pivotal cohort of its Phase 2 LEGEND trial. The data showed a high complete response rate and a favorable safety profile in challenging bladder cancer cases. See our latest analysis for enGene Holdings. enGene Holdings’ impressive momentum really kicked in after its recent LEGEND trial data sent the stock soaring, highlighted by a 40% seven-day share price return and a staggering 129% gain over...